Tian Hong-Juan, Zhang Jian-Wei, Wu De-Hua, Tang Da-Xing, Fu Jun-Fen
Department of Urology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
Department of Pediatric, Women and Children's Health Care Hospital, Shaoxing, Zhejiang 312000, China.
Zhonghua Nan Ke Xue. 2016 Sep;22(9):843-849.
Disorders of sex development (DSD) is defined as a congenital condition or atypical development of the chromosomal, gonadal, or anatomic sex. The diagnosis, gender assignment, and treatment of DSD require the guidance from experienced multidisciplinary teams. So far there has been no consensus about it in China. Due to dysgenetic gonads, defects in sex steroid biosynthesis or action, or gonadectomy during the prepubertal years, those with DSD suffer from hypogonadism. The hormone replacement therapy of DSD aims at general physiological health and long-term prognosis as well as the avoidance of unnecessary genital and gonadal surgery. This review focuses on the advances in the studies of the diagnosis and hormone replacement therapy of 46,XY DSD.
性发育障碍(DSD)被定义为染色体、性腺或解剖学性别方面的先天性状况或异常发育。DSD的诊断、性别认定和治疗需要经验丰富的多学科团队的指导。到目前为止,中国对此尚未达成共识。由于性腺发育不全、性类固醇生物合成或作用缺陷,或青春期前进行性腺切除术,患有DSD的患者会出现性腺功能减退。DSD的激素替代疗法旨在促进总体生理健康和长期预后,并避免不必要的生殖器和性腺手术。本综述重点关注46,XY DSD诊断和激素替代疗法的研究进展。